Frontotemporal lobar degeneration: Study of a clinicopathological cohort

J Clin Neurosci. 2018 Dec:58:172-180. doi: 10.1016/j.jocn.2018.10.024. Epub 2018 Oct 19.

Abstract

Frontotemporal dementia results from different neurodegenerative diseases heterogeneous from a clinical, neuropathological and genetic point of view. Our main objective was to analyze the sociodemographic, clinical, neuropathological and molecular characteristics of cases with frontotemporal lobar degeneration from different Neurological Tissue Banks. FTD has been considered as a disease with onset below 65. However, diagnosis at higher ages is increasingly common. In our study, there was a correlation between symptoms and disease course with certain neuropathological diagnoses, with different distribution depending on age and sex. Combined pathology with Alzheimer's and vascular pathology was observed and presence of argyrophilic grains, with a different distribution in the different subgroups and a particular clinical and progression phenotype. Low percentage of APOE4 was detected. H1/H1 haplotype of the MAPT gene was the most frequent and appeared in relationship with 4R tauopathies. These results point to biologically significant differences between the different types of FTLD.

Keywords: Frontotemporal dementia; Frontotemporal lobar degeneration; Neuropathology.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Female
  • Frontotemporal Lobar Degeneration / classification*
  • Frontotemporal Lobar Degeneration / genetics*
  • Frontotemporal Lobar Degeneration / pathology*
  • Humans
  • Male
  • Middle Aged